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Purpose: Although all contact lenses (CLs) are applied initially to the eye directly from a packaging solution, little is
known about the effects of these solutions on human corneal epithelial cells (HCECs). Due to the porous nature of CL
materials, they have the potential to sorb components of the packaging solution during storage, which could then be
subsequently released upon insertion of the CL on the eye. The purpose of this study was to investigate the effect of various
packaging solutions on HCECs, using an in vitro model.
Methods:  An  in  vitro  assay  was  developed  whereby  various  silicone  hydrogels  and  conventional,  poly-2-
hydroxyethylmethacrylate  (polyHEMA)-based lens materials were removed directly from their packaging and then
incubated for up to 24 h with HCECs. The effect of the retained and released packaging solution components on HCECs
was assessed by measuring cell viability, adhesion phenotype, and apoptosis.
Results: Incubation of HCECs with CLs stored in borate-buffered packaging solutions resulted in a significant reduction
in cell viability. Adherent cells incubated with these CLs also exhibited reduced levels of β1 and α3 integrin. Soaking
borate-buffered packaged CLs in PBS before cell incubation resolved viability and integrin expression in all cases, with
the exception of galyfilcon A and balafilcon A, from which a 20% reduction in cell viability was still observed. In
comparison, CLs stored in phosphate-buffered packaging solutions had cellular viability and expression of integrins
similar to control cells (cells incubated in the absence of a lens). When incubated with cells at a 10% concentration in
serum-free medium, borate-buffered packaging solutions and borate-containing saline (Unisol 4) significantly reduced
cell viability and integrin expression. Neither caspase activation nor annexin V binding was observed on cells following
exposure to borate buffer solution. However, a significant decrease in reactive oxygen species was observed at 24 h. These
latter results suggest that in vitro exposure to low concentration of borate/boric acid results in cell dysfunction, leading
to necrosis rather than apoptosis.
Conclusions: Borate-buffered packaging solutions were shown to adversely affect the viability and integrin expression
of HCECs in vitro. When used in ophthalmic packaging solutions, the antimicrobial properties of borate buffer may be
outweighed by its relatively cytotoxic effects on cells.
Chemical properties such as oxygen permeability [1] and
wettability [2], in addition to protein and lipid sorption [3-6],
have been the primary focus of most studies investigating the
biocompatibility of contact lens materials with the external
ocular  surface.  Recently,  potential  issues  with  various
components  of  multi-purpose  cleaning  solutions  and  the
preservative  agents  contained  therein  have  led  to  in  vitro
studies whereby these solutions, at various concentrations, are
tested  directly  on  conjunctival  or  epithelial  cells  [7-11].
Contact lens material parameters such as water content, the
presence of various functional groups, surface treatment, and
the nature of the underlying polymeric matrix can affect the
uptake and subsequent release of various components from
care regimens that come into contact with the lens materials
[12]. A recent study with benzalkonium chloride, a common
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preservative used in ophthalmic solutions, demonstrated the
in vitro cytoxicity of extracts from contact lenses soaked in
benzalkonium chloride solutions [8]. A significant effect of
the lens material on the release of cytotoxic components was
found,  which  further  suggests  that  interactions  between
contact lens materials and the solutions that they contact may
have deleterious effects on the cornea.
Although all contact lenses are initially applied to the eye
directly from the packaging container in which the lens is
supplied, literature available on the direct effect of packaging
solutions on the ocular surface remains sparse. Due to the
highly porous nature of hydrogel materials, soft contact lenses
have  the  potential  to  take  up  significant  quantities  of  the
components of ophthalmic solutions [12-14], which can be
subsequently released upon insertion onto the ocular surface.
The effects of these components on corneal epithelial cells
have not been widely studied. One study reported the effect
of borate versus phosphate buffered packaging solutions on
lens parameters [15]. While phosphate and borate buffers have
been used extensively in ophthalmic solutions, there is limited
Molecular Vision 2010; 16:272-282 <http://www.molvis.org/molvis/v16/a33>
Received 15 June 2009 | Accepted 15 February 2010 | Published 19 February 2010
© 2010 Molecular Vision
272knowledge of their biological effect on corneal epithelial cells.
Borate salts have been reported to have both cytotoxic and
anti-inflammatory effects on cells, depending on the borate
salt, its concentration, and the type of cells used [16-18]. A
recent study also reported that corneal epithelial cells treated
with 1% boric acid displayed discontinued tight junctions in
vitro [9]. The potential cytotoxic effects of borate buffers on
corneal  epithelial  cells  is  a  specific  concern  for  users  of
disposable  lenses,  since  they  are  removed  from  their
packaging solution and inserted onto the ocular surface daily.
Commercially  available  conventional,  polyHEMA-based
hydrogel and silicone hydrogel contact lenses are stored in
either  phosphate  or  borate  buffered  packaging  solutions. 
Therefore, this in vitro study was undertaken to investigate
the  effect  of  lens  release  on  corneal  epithelial  cells.  The
specific cellular effects studied were corneal epithelial cell
adhesion phenotype and viability.
METHODS
Reagents  and  antibodies:  The  keratinocyte,  serum-free
medium and supplement were from ScienCell (Carlsbad, CA).
All other cell culture reagents, Dulbecco’s minimum essential
medium, fetal bovine serum, phosphate buffer saline, and
TriplExpress were purchased from Invitrogen (Burlington,
Canada).  Monoclonal  antibodies  to  β1  integrin  (CD29;
Immunotech-Coulter,  Marseilles,  France)  and  β4  integrin
(CD104; Serotec, Mississauga, Canada) and ICAM-1 (CD54;
Immunotech-Coulter)  were  fluorescein  isothiocyanate
(FITC)  conjugates.  Monoclonal  antibodies  against  Fas
(CD95; Immunotech-Coulter), α3 integrin (CD49c; Serotec)
and  α6  integrin  (CD49f;  Serotec)  were  R-phycoerythrin
conjugates. To determine if, following incubation with the
contact  lenses,  cells  were  undergoing  apoptosis,  caspase
activation  was  measured  by  flow  cytometry  using  FITC-
VAD-FMK (EMD Biosciences, San Diego, CA). Annexin V-
FITC and YO-PRO-1 were from Molecular Probes (Eugene,
OR), 2’-7’ dichlorohydrofluorescein diacetate (DCF-A) from
Biotium  (Hayward,  CA),  and  Rhodamine  123  from
Invitrogen.  Paraformaldehyde  was  purchased  from  Fisher
Scientific (Ottawa, Ontario, Canada) and all other chemicals
used to prepare Hepes Tyrode Buffer were of analytical or
reagent grade (Sigma-Aldrich, Oakville, Canada). A sterile
solution of Unisol 4® (unpreserved borate-buffered saline;
Alcon, Fort Worth, TX) was purchased from a commercial
source and used within its expiration date.
Contact lenses: Both silicone hydrogel (SH) and polyHEMA-
based conventional hydrogel (CH) lenses were tested. Table
1 lists the disclosed information on the lenses and packaging
solutions used in the study. All lenses were obtained in their
original  packaging  from  the  manufacturer  and  had  14.0–
14.2  mm  diameters  and  8.50–8.70  mm  base  curvatures.
Unworn lenses were used in one of three states: directly from
the packaging container (no treatment), after being rinsed 3×
in  sterile  unpreserved  PBS  (PBS-rinsed),  and  after  being
soaked in sterile PBS for 24 h at room temperature (PBS-
soaked). All lens treatments were performed under sterile
conditions.
In vitro cell culture:
Immortalized human corneal epithelial cells—SV40-
immortalized human corneal epithelial cells (HCECs) were a
gift from Dr. M. Griffith (Ottawa Eye Research Institute,
Ottawa,  Canada)  and  have  been  characterized  as  human
corneal epithelial cells previously [19]. Cells were cultured in
keratinocyte serum-free medium supplemented with bovine
pituitary extract, recombinant epidermal growth factor, and
pen-strep (KSFM). Fresh medium was added every other day,
and cells were grown to 90% confluency in tissue culture-
treated  flasks.  Adherent  cells  were  removed  using  the
dissociation solution TriplExpress (Invitrogen).
In  vitro  model—An  in  vitro  model,  similar  to  that
reported by Maltseva et al. [20], was developed. HCECs were
seeded onto a 24-well tissue culture-treated polystyrene plate.
Cells were left to adhere for 3 h in a humid CO2 incubator
[21]. Supernatant was then removed and fresh serum-free
medium was added. Sterile CH and SH lenses were placed
gently on top of the monolayer, with the concave surface
facing upwards and incubated for up to 24 h at 37 °C (5%
CO2 in a humid incubator). Lenses were totally immersed in
TABLE 1. LENS CHARACTERISTICS AND DISCLOSED PACKAGING SOLUTION CONTENTS.
Manufacturer Brand name Lens material
(USAN)
Water content
(%)
Buffering
agent
Disclosed packaging
additive
Bausch & Lomb PureVision balafilcon A 36 Borate
SofLens 38 polymalcon 38 Phosphate 0.1% polyvinyl alcohol
SofLens 66 alphafilcon A 66 Borate
CIBA Vision Night & Day lotrafilcon A 24 Phosphate
Focus Dailies nelfilcon A 69 Phosphate 0.02% poloxamer
O2Optix lotrafilcon B 33 Phosphate 0.02% poloxamer
Johnson & Johnson 1-Day Acuvue (etafilcon
A-1day)
etafilcon A 58 Borate
Acuvue Advance galyfilcon A 47 Borate ≤0.01% methyl cellulose
Acuvue OASYS senofilcon A 38 Borate ≤0.01% methyl cellulose
Silicone hydrogel lenses are italicized.
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273medium in all cases. After 24 h, the lenses were carefully
removed from the wells. The lenses did not adhere to the
HCEC  monolayer,  and  HCECs  did  not  proliferate  on  the
contact lenses. In some cases, instead of testing a contact lens,
up to 70 μl of sterile packaging solution or Unisol 4 was
directly  added  to  the  adherent  cells  (corresponding  to
maximum final concentration of 10% in medium),followed
by 8–24 h incubation.
Control experiments included experiments in which cells
were also left to adhere for 24 or 48 h before incubation with
contact  lenses  or  borate  solution,  to  determine  if  initial
experimental  conditions  had  a  significant  effect  on  the
observed cytotoxic results. The effect of serum (10% final
concentration) on cytotoxicity was also determined.
Cellular viability: To evaluate the cytotoxicity of the products
released by the contact lenses, the 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium  bromide  (MTT)  assay  cellular
viability assay was performed [8]. After a gentle rinse in sterile
PBS,  cells  were  incubated  with  a  solution  of  3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide
(MTT at 1mg/ml in KSFM medium). After 3 h at 37 °C, cells
were lysed with dimethyl sulfoxide (DMSO) and absorbance
read at 595 nm [22,23]. All results are expressed as relative
viability compared to cells grown in the absence of a contact
lens.
Cellular  activation  and  apoptosis:  To  determine  cellular
activation and change in integrin expression induced by the
presence of the contact lens and release of packaging solution
components,  HCECs  were  removed  from  the  wells  with
TriplExpress  (Invitrogen).  Cells  were  washed  and
resuspended  in  Dulbecco's  Modified  Eagle  Medium/fetal
bovine serum. Small aliquots (25 μl) of HCECs, diluted in
DMEM-FBS, were incubated with saturating concentration of
fluorescently labeled antibodies for 1 h at 4 °C. Samples were
then diluted in Hepes Tyrode Buffer (137 mM NaCl, 2.7 mM
KCl, 16 mM NaHCO3, 5 mM MgCl2, 3.5 mM Hepes, 1g/l
glucose, 2 g/l bovine serum albumin, pH 7.4), fixed in 1%
paraformaldehyde, and analyzed by flow cytometry within 5
days.
To investigate the potential mechanisms involved in the
cytotoxicity, several markers of apoptosis were studied. For
caspase activation, 1 µl of FITC-VAD-FMK (Calbiochem,
San  Diego,  CA)  was  added  to  samples,  and  they  were
incubated at 37 °C with 5% CO2. Following incubation and
proper washing, samples were analyzed immediately on the
flow cytometer [24]. Binding of annexin V-FITC on the cell
membrane  and  permeability  to  YO-Pro-1  were  also
investigated. Annexin V binds to phosphatidylserine, which
becomes exposed to the outer leaflet of the apoptotic cell
membranes. YO-PRO-1 is a fluorescent DNA probe that is
permeable  through  the  membrane  of  apoptotic  cells.
Permeability to YO-PRO-1 has been linked to pores formed
following apoptosis induced by activation of the P2X7 cell
death receptor [25] or reactive oxygen species production
[26]. Cells were incubated with 1 μl of each fluorescent dye
in  separate  tubes  for  30  min,  washed,  and  analyzed
immediately on the flow cytometer. To further characterize
the  potential  mechanisms  involved  in  cell  death,  the
intracellular  levels  of  reactive  oxygen  species  were  also
measured using DCF-A. DCF-A was dissolved in DMSO at
4 mg/ml and further diluted in KSFM to 0.08 mg/ml. A small
aliquot  of  cells  (30  μl)  were  stained  with  DCF-A  (final
concentration 4 μg/ml) at 37 °C for 30 min. In parallel, as a
positive control, cells were also stained with DCF-A in the
presence of Phorbol 12-Myristate 13-Acetate (a potent protein
kinase C [PKC] activator) to further stimulate reactive oxygen
species production. Loss of mitochondria membrane potential
was assessed using Rhodamine 123 (Rh123). A stock solution
of Rh123 was diluted in ethanol to 1 mg/ml and further diluted
in KSFM to 10 μg/ml on the day of the experiments. Rh123
was added to cells (final concentration 2 μM) and incubated
at 37 °C for 30 min. Both Rh123 and DCF-HA were analyzed
immediately  by  flow  cytometry  following  the  37  °C
incubation.
All flow cytometric measurements were acquired on a
Becton Dickinson FACSVantage flow cytometer (Mountain
View, CA) using CELLQuest Software (Becton Dickinson,
Mountain View, CA). Appropriate isotype controls were used
with each experiment. Data analysis was performed using
FACSExpress (DeNovo Software, Los Angeles, CA).
Statistical  analysis:  All  results  are  reported  as  means
±standard deviation (SD). To evaluate the significance of the
differences in cell viability and cell activation, analysis of
variance (ANOVA) was performed, followed by a post hoc
Tukey test using the statistical analysis software Statistica
(Tulsa, OK). A p value of less than 0.05 was required for
statistical significance. The number of experiments was equal
to or greater than three.
RESULTS
Cell viability: Following 24 h incubation with lenses stored in
borate-buffered packaging solutions, microscopic evaluation
revealed  the  appearance  of  bare  patches  within  the  cell
monolayer, suggesting cell death and/or impaired adhesion
(Figure 1). In comparison, no difference could be observed
between HCECs exposed to lotrafilcon A lenses and cells
cultured in the absence of a lens.
After 24 h incubation with contact lens materials directly
out of the packaging solution, a 40% reduction or more in cell
viability (p<0.001) was observed for all contact lenses stored
in  borate-buffered  packaging  solutions  (Table  2).  In
comparison, incubation in the presence of lenses stored in
phosphate-buffered  packaging  solution  did  not  lead  to
significantly reduced cell viability. These results were further
confirmed with HCECs that were left to adhere for up to 48 h
before incubation with the daily disposable lenses nelfilcon A
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274(phosphate-buffered solution) and etafilcon A-1 day (borate-
buffered  solution;  Table  3).  Furthermore,  the  presence  of
serum did not have a protective effect against cytotoxicity that
was observed with etafilcon A-1 day (Table 3).
The cytotoxicity to HCECs of borate-buffered packaging
solutions  was  then  directly  assessed  by  adding  sterile
packaging solutions from galyfilcon A and balafilcon A lenses
to  the  culture  medium  (10%  final  concentration).  As
illustrated in Table 4, a 10% dilution of solutions containing
borate led to a significant reduction in cell viability after both
8 and 24 h exposures. Interestingly, at 8 h, a similar reduction
in cell viability was observed between 10% borate buffer
solution and products released from a contact lens. Yet at 24
h, a significantly more pronounced reduction in cell viability
was  observed  with  the  direct  addition  of  the  packaging
solution to the medium, compared to the change in viability
observed  with  release  from  the  etafilcon  A-1day  and
balafilcon A lenses. Other packaging solutions from lenses
listed in Table 1 were also tested on HCECs (data not shown),
which confirmed the results presented in Table 4. Adding
Figure 1. Micrographs of adherent human corneal epithelial cells after 24 h incubation with a contact lens. Corneal epithelial cells were
incubated for 24 h in the presence of lotrafilcon A, directly out of its phosphate-buffered packaging solution and balafilcon A, directly out of
its borate-buffered packaging solution. No lens represents the control cells, i.e., corneal epithelial cells grown in the absence of a contact lens.
TABLE 2. VIABILITY OF HCEC FOLLOWING A 24 H INCUBATION WITH CONTACT LENSES AND THE EFFECT OF RELEASE FROM CONTACT
LENSES STORED IN BORATE OR PHOSPHATE BUFFERED PACKAGING SOLUTIONS.
Lens storage conditions Lens Viability
Lens stored in borate buffered packaging solution balafilcon A 56±7*
  alphafilcon A 59±7*
  etafilcon 1 day 63±10*
  galyfilcon A 55±8*
  senofilcon A 60±8*
Lens stored in phosphate buffered packaging solution nelfilcon A 100±6
  lotrafilcon A 88±7
  lotrafilcon B 90±8
  polymalcon 98±3
TABLE 3. EFFECT OF EXPERIMENTAL CONDITIONS ON CELL VIABILITY FOLLOWING INCUBATION WITH A CONTACT LENS OR TEST SOLUTION.
Test sample 3 h settling 3 h settling + 10% FBS 24 h settling 48 h settling
Etafilcon A 63±10* 60±11* 73±3* 71±4*
Nelfilcon A 94±5 98±8 92±10 100±4
Unisol (10%) 60±4* ND 68±5* 74±5*#
PBS (10%) 102±6 ND 101±6 98±7
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Viability was measured by MTT assay and is expressed as a percentage relative to cells incubated for the same time in the
absence of a contact lens (control). n=3 to 5, the asterisk indicates significantly different from cells grown in the absence of a
lens p<0.01.
After the mentioned settling time, cells were incubated for 24 h with the test material or solution. Viability was measured by
MTT  assay at the end of the incubation period and expressed relative to control (cells grown in the absence of lens and solution).
The asterisk indicates significantly different from lotrafilcon A (lens stored in a phosphate buffered solution), p<0.003. The
sharp indicates significantly different from incubation with Unisol after a 3 h settling period p=0.032. ND indicates not
determined.phosphate-buffered packaging solution (from comfilcon A,
nelfilcon A, polymacon, and lotrafilcon B) to the medium
(10%  final  concentration)  did  not  affect  cell  viability
(p>0.05).  As  packaging  solutions  contain  additives  and
preservative agents that may affect the observed cytotoxicity,
Unisol 4 (Alcon), an unpreserved borate-buffered solution,
was tested at various concentrations on cells. The solution
contained 0.5% boric acid and 0.052% sodium borate, as well
as  0.66%  sodium  chloride  (H.  Ketelson,  Alcon,  personal
communication, 2009). The overall concentration of borate/
boric content of Unisol was 0.55%, for the results presented
herein. When compared to exposure to PBS and no solution,
a significant effect from borate buffer on cell viability was
observed at all concentrations above 0.025% (p<0.03; Figure
2). The effect of the concentration was consistent over the
different culture conditions (3 h, 24 h, and 48 h of culture prior
to testing; data not shown).
To further examine the cytotoxic effect of the products
released  from  lenses  stored  in  borate-buffered  packaging
solution, two CH materials (etafilcon 1day and alphafilcon A)
and two SH materials (galyfilcon A and balafilcon A) were
rinsed or soaked for 24 h in PBS. As illustrated in Figure 3,
soaking  lenses  in  PBS  for  24  h  before  cell  exposure
significantly increased cell viability, although a difference in
the viability of control cells was still observed with galyfilcon
A and balafilcon A (p<0.05). Simply rinsing contact lenses in
PBS  improved  cell  viability  only  for  the  borate-buffered
lenses with galyfilcon A and alphafilcon A (p<0.035).
Cell  activation,  integrin  expression,  and  apoptosis:  To
characterize the phenotype of adherent cells at the end of the
incubation with a contact lens, flow cytometry analysis was
performed with a selection of materials (etafilcon A-1day,
galyfilcon A, balafilcon A, and lotrafilcon A). Neither Fas,
Fas ligand, nor ICAM-1 was upregulated in the presence of
the contact lenses tested. In comparison, a significant decrease
in the expression of α3 and β1 (Table 5) was observed with
lenses stored in borate-buffered packaging solutions. Soaking
the lenses in PBS for 24 h prevented any deleterious effect on
TABLE 4. EFFECT OF PACKAGING SOLUTION ON CORNEAL EPITHELIAL CELL VIABILITY AS MEASURED BY THE MTT ASSAY.
Figure 2. Effect of borate/boric acid on
HCEC viability. Cells were incubated
for 24 h with different concentrations of
Unisol,  a  saline  solution  containing
borate/boric  acid.  Viability  was
measured by 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium  bromide
(MTT)  assay  and  is  expressed  as  a
percentage relative to cells grown in the
absence of a solution (control); n=3–4.
The  asterisk  indicates  significant
difference from control, p<0.001.
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Packaging solution from
Contact time etafilcon A-1 day
(borate based)
balafilcon A 
(borate based)
lotrafilcon A
(phosphate based)
Borate buffer
solution (Unisol 4)
8 h 70±6* 76±1* 100 ND
24 h 45±2* 43±2* 91±4 60±4*
All solutions were diluted to a final concentration of 10% in KSFM. Results are expressed as a percentage compared to the
control (cells incubated in KSFM medium only). The asterisk indicates significantly different from cells grown in the absence
of a lens p≤0.04; ND indicates not determined. Note; incubation with etafilcon 1 day lens resulted in a viability of 75±7* at 8
h and 60±6* at 24 h.integrin  expression.  A  small  decrease  in  β4  expression,
although not statistically significant, was observed for cells
incubated  with  lenses  from  borate-buffered  packaging
solution  (Table  4).  Adding  balafilcon  A  borate-buffered
packaging  solution  to  the  cell  culture  medium  at  a
concentration of 10% also resulted in a significant reduction
in α3, β1, and β4, in a magnitude similar to that observed from
HCECs exposed to a balafilcon A lens (Table 6).
As shown in Figure 4, caspase activation, detected using
FITC-VAD-FMK, was not observed in cells incubated for 24h
with borate buffer-containing solutions. The percentage of
cells staining positive for caspase activity (5±2%) was similar
Figure 3. Effect of PBS rinse or soak on
viability  of  corneal  epithelial  cells
exposed to contact lenses. Prior to the
cell  experiment,  contact  lenses  were
rinsed  three times in sterile PBS (PBS-
rinsed) or soaked in PBS for 24 h (PBS-
soaked)  under  sterile  conditions.
Although lotrafilcon A lens packaging
solution is based on phosphate buffer,
lotrafilcon  A  was  also  submitted  to
similar  PBS  treatments  for  controls.
Viability  was  measured  by  3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay and
expressed  as  a  percentage  relative  to
cells grown in the absence of a contact
lens  (control);  n=3–5.  The  asterisk
indicates  significant  difference  from
cells  grown  in  the  absence  of  a  lens
(p<0.005).  The  sharp  symbol  (hash
mark)  indicates  significant  difference
from the PBS-rinsed lens, p<0.005.
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TABLE 5. EFFECT OF PACKAGING SOLUTION RELEASED FROM CONTACT LENS ON INTEGRIN EXPRESSION OF CORNEAL EPITHELIAL CELLS AFTER INCUBATION FOR 24 H.
Lens stored in borate buffer packaging solution
Lens stored in phosphate buffer
packaging solution
etafilcon A-1day galyfilcon A balafilcon A lotrafilcon A
Integrin No treatment PBS-soaked No treatment PBS-soaked No treatment PBS-soaked No treatment PBS-Soaked
α3 72±5# 98±6 81±5* 100±4 72±8# 92±5 92±7 99±5
α6 93±9 95±4 95±14 94±5 95±11 100±9 93±4 96±6
β1 83±3* 95±5 85±6* 97±2 83±2* 98±3 98±3 100±0
β4 87±5 98±4 89±9 97±4 88±11 100±5 96±7 101±5
Cells were incubated for 24 h with contact lenses directly out of packaging or after a 24-h soak in PBS. Integrin expression is
expressed as a percentage relative to its expression on cells grown in the absence of a contact lens (control). n=3 to 4, the asterisk
indicates significantly different from control, p<0.05 and the sharp indicates significantly different from control, p<0.01.
TABLE 6. INTEGRIN EXPRESSION FOLLOWING A 24 H INCUBATION WITH PACKAGING SOLUTIONS (FINAL CONCENTRATION: 10%
DILUTED IN MEDIUM) AND BORATE BUFFER.
Integrin Balafilcon A packaging solution Unisol 4 (BBS) PBS
α3 59±13* 75±3* 98±7
β1 71±7* 80±10* 98±3
Integrin expression is expressed as a percentage relative to cells grown in the absence of a contact lens (control). n=3, the asterisk
indicates significantly different from cells grown in the absence of a lens p<0.05.for cells grown in the absence of solution, or in the presence
of PBS or Unisol. This was done with concentrations of up to
0.1% borate/boric acid (i.e., 20% Unisol), which were tested
at 24 h; caspase activation remained within control levels.
After 24 h exposure to diluted borate solutions, there was also
no significant increase in binding of annexinV-FITC between
cells exposed to diluted borate or phosphate solutions and
control cells (cells incubated in the absence of solution and
contact lens). For all samples, less than 2% of cells were found
to bind Annexin V. In the presence of borate solution, a small
but not significant increase in YO-PRO-1 permeability was
observed  (Table  7).  To  further  characterize  the  potential
mechanisms of borate-induced cytotoxicity, the intracellular
levels of reactive oxygen species (ROS) were measured. As
shown in Figure 5, a significant underproduction of DCF-A
was  observed  for  cells  that  had  been  exposed  to  borate-
buffered solution for 24 h, either from products released from
a lens or from direct dilution. A 25% reduction in fluorescence
intensity of rhodamine 123 (Figure 5) was also observed with
these  samples.  Upon  phorbol  myristate  acetate  (PMA)
stimulation, all cells were able to increase their production of
ROS (Table 8). As expected, the levels of PMA-induced ROS
in cells exposed to diluted borate solutions for 24 h were lower
than those of controls (since they had lower levels of ROS to
start with). Only cells exposed to 0.1% borate/boric acid (20%
unisol) for 24 h showed an impaired response in PMA-induced
ROS formation. All other cells exhibited 50% increases in
ROS production, suggesting that while they had an impaired
level  of  intracellular  ROS  after  24  h-exposure  to  borate-
buffered solution, they were still able to respond to PMA
stimulus.
DISCUSSION
While several in vitro studies have looked at the cytotoxicity
of multi-purpose lens-cleaning solutions, there is little data
available on the potential cytotoxicity of packaging solution
on  human  corneal  epithelial  cells  and  how  adsorbed
compounds from the packaging solutions can be released from
the contact lens and induce a cellular response in vitro. The
results obtained from epithelial cells placed in contact with
hydrogel  contact  lenses  stored  in  phosphate-buffered
packaging  solution  demonstrated  almost  100%  viability,
which confirmed the validity of our in vitro onlay model, and
also suggested that lenses stored in borate-buffered packaging
solutions affect corneal epithelial cells in vitro. Because of its
microbiological properties [27], borate buffer is used in many
ophthalmic  solutions,  including  contact  lens  disinfecting
solutions and lubricating eye drops. The significant reduction
in cell viability and the change in integrin expression in the
presence  of  Unisol  4,  an  unpreserved  borate-buffered
Figure 4. Caspase activation following
incubation  with  phosphate  or  borate-
buffered solution. No increase in cells
staining positive for FITC-VAD-FMK
was observed after cells were incubated
for 24 h with either phosphate, borate-
buffered  solutions,  or  soaked  lenses.
Dot plots are representative of the three
experiments that were performed.
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TABLE 7. YO-PRO 1 PERMEABILITY ON HCEC FOLLOWING 24 H EXPOSURE TO PHOSPHATE AND BORATE BUFFERED SOLUTION.
Medium alone YO-PRO-1 expression (%) cells staining positive for YOPRO-1 (%)
Medium alone 100% 2.5±1.2
0.055% borate/boric acid* 121±20 3.0±1.7
0.025% borate/boric acid 105±7 2.6±0.8
0.0055% borate/boric acid 106±5 3.1±0.4
0.16% phosphate# 102±3 4.0±0.4
The asterisk corresponds to a 10% dilution of BBS (Unisol 4) in medium and the sharp corresponds to a 10% dilution of PBS
in medium.solution, observed in our experiments further confirm the
potential adverse effects of borate buffer on corneal epithelial
cells in vitro, although their effect in vivo remains an area that
requires further study.
While many researchers have studied the cytotoxicity of
multi-purpose solutions, there are currently very few studies
that  have  investigated  borate  buffer  cytotoxicity,  a  buffer
widely used in the ophthalmic industry. Borate buffer used in
ophthalmic products is usually composed of boric acid (at less
than 1%) and borate sodium (at less than 0.3%) in a 0.9% NaCl
solution [28]. Poor in vivo corneal response to Unisol 4 has
previously  been  reported  by  Chang  et  al.  [29].  While
Santodomingo-Rubido [18] looked at the cytotoxicity of boric
acid  on  Chinese  hamster’s  lung  fibroblasts,  the  potential
cytotoxicity of borate buffer on HCECs does not appear to
have been studied in vitro. Our study compared the borate
buffer  released  from  contact  lenses  to  a  10%  dilution  of
Unisol,  which  would  be  equivalent  to  a  boric  acid
concentration of 0.055%. 1% boric acid has been shown to
alter tight junctions on corneal epithelial cells [9]. Our results
for the presence of Unisol 4 or borate-buffered packaging
solutions, showing reduced viability and integrin expression
on corneal epithelial cells, provide further information on the
potential effect of boric acid at a lower concentration than that
tested by Imayasu [9].
In vitro models using immortalized HCECs have been
used  recently  to  assess  the  potential  cytotoxicity  of
ophthalmic solutions [7,9,11]. Contact lens extracts, dilution
of solution, and short direct contact with ophthalmic solutions
have  all  previously  been  tested  on  monolayer  [8-11]  and
multilayer cell models [30]. However, to our knowledge, this
is the first time that the potential cytotoxicity of solutions has
been tested using an onlay model with corneal epithelial cells.
Concurrent  with  our  experiments,  Maltseva  et  al.  [20]
reported the development of a similar in vitro model, by which
cells at 20% confluence were grown in the presence of a
contact lens for up to 3.5 days, to assess their response to a
bacterial challenge. In agreement with our results, they did not
observe any cytotoxic effect from the polymacon A lens, a
lens  stored  in  a  phosphate-buffered  packaging  solution.
Repeating  their  experiments,  we  found  similar  results  for
lenses stored in phosphate-buffered solution, but a significant
Figure 5. Effect of borate/boric acid on
reactive oxygen species production and
mitochondrial permeability. Cells were
incubated  for  24  h  with  different
concentration  of  Unisol,  a  saline
solution  containing  borate/boric  acid.
Reactive  oxygen  species  (ROS)  was
measured  with  dichlorohydro-
fluorescein diacetate and mitochondrial
permeability was assessed with Rh123.
Results are expressed as a percentage
relative to cells grown in the absence of
a solution (control); n=3–4. The asterisk
indicates  significant  difference  from
control, p<0.01.
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TABLE 8. PMA-INDUCED ROS SYNTHESIS IN HCEC AFTER 24 H EXPOSURE TO PHOSPHATE OR BORATE BUFFERED SOLUTIONS.
Sample PMA-induced DCF Fluorescence intensity
(absolute value)
Increase relative to
unstimulated sample (%)
Medium alone 95±8 152±8
0.10% borate/boric acid 44±6 126±14*
0.055% borate/boric acid 53±9 145±2
0.025% borate/boric acid 53±11 141±3
0.0055% borate/boric acid 71±11 161±2
0.16% phosphate 95±9 159±2
The asterisk indicates significantly different from control cells (medium alone), p<0.01.reduction in cell proliferation (up to 50%) was observed for
lens materials stored in borate-buffered packaging solution.
While such an incubation model (20% confluency) is extreme
for testing the potential release of cytotoxic products from a
contact lens, it further emphasizes the deleterious effect that
borate-buffered packaging solutions have on HCECs. This
may  have  some  implications  for  corneal  wound  healing.
Further  studies  are  warranted,  to  determine  the  specific
mechanisms involved.
In the present study, both a 10% solution and the products
directly released from contact lenses were examined. At 24 h
of  exposure,  a  difference  in  the  results  for  viability  and
integrin expression was observed between direct tests of the
packaging solution and tests of the solution released from
contact lenses. This suggested that the products released from
the  contact  lenses  led  to  a  final  solution  concentration
equivalent to less than 10% of the borate buffer.
Due to their nature, there is always a concern that in vitro
models may overestimate the cytotoxicity of a product. A
monolayer  of  HCECs,  as  opposed  to  the  multilayered
structure of the cornea, was also used. Several experiments
were performed to ensure that our results were not an artifact
of the experimental conditions. Increasing cell culture time
before stimulus or adding 10% serum did not change the
observed  cytotoxicity  of  lenses  stored  in  borate-buffered
packaging solution. Furthermore, in these experiments and
others related to the solution released from contact lenses, we
also observed that there was a difference between using a
diluted solution and using a solution of products released
directly from a lens. During various ongoing investigations in
our  laboratories,  an  increased  cytotoxic  response  has
generally been observed when using diluted solutions. This
emphasizes the importance of testing products released from
the materials, rather than testing the solution only, because the
mechanisms  and  the  profile  of  cytotoxicity  may  differ
significantly, depending on both the chemistry of the lens and
its surface treatment. Lens type has been previously observed
to  have  a  significant  effect  on  the  uptake  and  release  of
polyhexamethylene biguanide (PHMB)-containing solutions
[31]. Our model was able to identify differences between
lenses based on storage conditions. In vivo data on the effects
of borate have shown a deleterious effect on rabbit corneas
[29].  A  recent  clinical  study  [32]  regarding  the  risk  of
microbial keratitis in daily disposable-lens wearers reported
that lenses packaged in borate buffer (etafilcon A-1 day) were
relatively less risky than lenses packaged in phosphate buffer
(nelfilcon  A).  While  the  authors  did  not  comment  on
packaging  solutions,  they  discussed  the  more  difficult
handling of nelfilcon A, which could lead to corneal abrasions
and possible increased predisposition to infection. Factors
other than packaging solutions therefore appear to play a more
important role in the risk for microbial keratitis.
In parallel to measuring the effect of packaging solutions
on cell viability, integrin expression and markers of activation
on  adherent  cells  were  also  characterized.  ICAM-1  is  a
receptor  involved  in  leukocyte  adhesion,  which  has  been
found to be upregulated upon cell activation [33,34]. The fact
that  ICAM-1  was  not  upregulated  in  the  presence  of  the
contact lens further confirms the material biocompatibility of
contact  lenses.  In  the  presence  of  the  release  of  borate-
buffered packaging solution, reduced expression of α3, β1, and
β6 was observed. Studies on corneal cell adhesion have shown
integrin  expression  to  be  upregulated  in  the  presence  of
specific extracellular matrix proteins or glycoproteins, such
as laminin or collagen type IV [35]. Upon cell migration,
which occurs as part of wound healing, integrin expression
remains stable, although a relocation of the different integrins
on the cell membrane occurs [36]. Thus, from our studies, the
reduced integrin expression induced by the release of borate-
buffered packaging solution suggests that the mechanism of
adhesion  of  corneal  epithelial  cells  has  been  adversely
affected.
The α3 and β1 integrins have also been localized at cell-
cell attachment junctions [37,38]. The observed reduction in
α3 and β1 may also suggest that in our in vitro model, tight
junctions were affected by the presence of 0.1% or less boric
acid, and further supports observations for 1% boric acid made
by Imayasu et al. [19]. α3 and β1 integrins have also been
referred to as “survival integrins” [36], and their reduced
expression in the presence of borate buffer may suggest that
cells  are  undergoing  apoptosis.  As  a  means  to  further
characterize the mechanisms involved in borate’s cytotoxicity
to cells, various markers of apoptosis were assessed. Fas had
been previously reported to be upregulated in conjunctival
corneal cells following inflammatory stimulus [39,40]. The
lack of Fas upregulation, the lack of staining activation for
caspase, and the absence of significant changes in staining
with YO-PRO-1 and Annexin V suggest that apoptosis is not
being induced by borate-containing solutions, and that the
stress from exposure to borate buffer-based solutions may
lead to necrosis, rather than inducing apoptosis. It is also
possible  that  a  caspase-independent  pathway  such  as
endonuclease G, or a secondary necrosis, is being triggered,
following  exposure  to  borate/boric  acid.  Further
investigations will be required to elucidate other potential
apoptotic  mechanisms.  While  the  pathways  of  cell  death
induced by apoptosis have been well characterized, there is
little known about mechanisms involved in necrosis [41]. The
reduced level of DCF-A observed in cells following 24 h
exposure to a low concentration of borate/boric acid may be
indicative  of  previous  extracellular  release  of  ROS  or
impaired  function.  The  lower  mitochondrial  permeability
observed in cells after 24 h with borate-containing solution
further suggest that the cells had been functionally damaged.
Prior studies have shown both increased and decreased ROS
production  during  short  exposure  to  ophthalmic  solutions
[26,42]. After exposure to borate-containing solution for 2–4
h  (data  not  shown),  we  observed  an  increase  in  ROS
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underproduction and decreased mitochondrial permeability
we observed at 24 h.
In  conclusion,  the  in  vitro  contact  lens  onlay  model
reported in this study appears to be a valuable tool for studying
the direct release of ophthalmic solutions on human corneal
epithelial  cells.  These  in  vitro  studies  demonstrated  that
borate-buffered  packaging  solutions  significantly  affect
corneal cell viability, as well as their adhesion phenotype. The
potential cytotoxic effect of borate buffer on corneal epithelial
cells was further demonstrated using a diluted solution of
Unisol 4. Concentrations of borate/boric acid of less than
0.06% were shown to significantly alter cell phenotype. Our
results suggest than necrosis, rather than apoptosis, is induced
by exposure to borate-containing solutions, and that ROS may
play a role. While borate-buffered saline is recognized for its
microbiological properties, its relative cytotoxic effects on
cells observed in vitro may outweigh the benefits of using it
in packaging solutions, especially for daily disposable lenses,
when corneas would be exposed to new, “soaked” lenses
every  day.  Other  parameters,  such  as  packaging  solution
additives, mechanical factors, and regimen compliance, may
also  play  a  role.  These  need  to  be  considered  in  clinical
situations.
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